Unreal Engine: from gaming to ground-breaking cures
It generally takes between ten and 12 years to bring a new drug to market, and the initial discovery and…
All articles by Elliot Gardner
Elliot Gardner
-
-
Hereditary Alzheimer’s: could rare genes hold the key to a cure?
Hereditary disposition towards the development of Alzheimer’s is a concern for many with family members who have lived with the…
-
Could digital tech unlock billions in savings for pharma companies?
In March, professional services and management consulting company Accenture announced that by investing in digital technologies, the UK pharmaceutical industry…
-
Tracing the story of mumps: a timeline
The Evolution of Mumps Through History The mumps virus is highly contagious, spreading rapidly, and can lead to complications including…
-
Award-winning pharma packaging
Launched in 1977 and organised by UBM, Pharmapack Europe has become the pharmaceutical industry’s dedicated packaging, drug delivery, medical device…
-
Hemophilia B gene therapy race heats up following Fitusiran’s failure
Removing the need for a regular infusion of the missing Factor IX (FIX) is a long-term goal for the treatment…
-
US drug imports: a recipe for disaster?
Would importing drugs from foreign markets be a good way to improve patient access to medication? It’s a question that…
-
The gene-silencing approach to cutting cholesterol
High cholesterol is a major problem in the developed world. One of the leading causes of heart disease – and…
-
Pooling resources for clinical trials
Adaptive clinical trials are becoming increasingly commonplace. Unlike traditional approaches to clinical trials – which lock in the study’s design…
-
Alzheimer’s drugs: will 2017 bring better news?
Up to this point, clinical trials for Alzheimer’s disease have had an incredibly high failure rate, a combination, researchers say,…